News Focus
News Focus
Followers 42
Posts 33944
Boards Moderated 0
Alias Born 07/08/2003

Re: Tekterra post# 4184

Tuesday, 07/18/2017 12:05:59 PM

Tuesday, July 18, 2017 12:05:59 PM

Post# of 7747

I've been digging Albumin binding mechanism. The nano particle deliver mechanism isn't unheard off.



Well sure, but the method of deploying albumin binding is different in each drug. The method used in LADR is apparently inferior to the method used to produce Abraxane. If LADR was equal or superior CYTR would actually be a buyout candidate. I find one of the most amusing, and troubling, events in the sordid history of stock manipulation the CYTR awarding of 180K insider options the day before issuing the 12/11/13 PR that caused the share price to more than double in next two days.

If nothing else, CYTR management is consistent in their desire to enrich themselves at the expense of shareholders.

“A bank would never get away with what the Department of Education is doing.”

Sheila Bair

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today